DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Emami H, Vucic E, Subramanian S. et al.
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Atherosclerosis 2015;
240: 490-496
DOI: 10.1016/j.atherosclerosis.2015.03.039. (PMID: 25913664)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.